NewsRx

Search our medical news database

Financing

TriReme Medical Inc. Announces $15.5 Million Series C Financing

Published in Medical Device Law Weekly, November 4th, 2007

TriReme Medical Inc. (TMI), a developer of novel stents and stent delivery systems for vascular lesions at or near bifurcations, announced the successful completion of its $15.6 million Series C financing led by Three Arch Partners and completed by Adams Street Partners. Joining the Company's Board of Directors will be Mark Wan of Three Arch Partners and Michael Lynn, MD, of Adams Street Partners. The funds will be used to continue the development of the company's novel stent system and to support ongoing clinical studies. "We are thrilled to have the support of such a premier group of investors with vast experience and deep understanding of the medical device space," said Eitan...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Device Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook